1-溴-4-(环戊基磺酰基)苯 | 173387-45-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-溴-4-(环戊基磺酰基)苯
• 中文别名: 1-溴-4-(环戊烷磺酰基)苯
• 英文名称: 4-bromophenyl cyclopentyl sulfone
• 英文别名: 1-bromo-4-(cyclopentylsulfonyl)benzene；4-bromo-(cyclopentylsulfonyl)benzene；1-Bromo-4-(cyclopentanesulfonyl)benzene；1-bromo-4-cyclopentylsulfonylbenzene
• CAS: 173387-45-6
• 化学式: C₁₁H₁₃BrO₂S
• 分子量: 289.193
• InChiKey: FEVMOUOFLLDHPH-UHFFFAOYSA-N

物化性质

• 沸点：
  413.6±37.0 °C(Predicted)
• 密度：
  1.504±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  42.5
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2904909090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1-Bromo-4-(cyclopentanesulfonyl)benzene
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1-Bromo-4-(cyclopentanesulfonyl)benzene
CAS number: 173387-45-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H13BrO2S
Molecular weight: 289.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-溴-4-(环戊基磺酰基)苯 在 hexadecyltributylphosphonium azide 作用下， 以 甲苯 为溶剂， 生成 叠氮环戊烷
  参考文献：
  名称：

  The SN2 displacements at 2-norbornyl brosylates

  摘要：

  DOI：

  10.1021/ja00377a057
• 作为产物：
  描述：

  4-溴苯硫酚 在 sodium hydride 、 间氯过氧苯甲酸 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 、 mineral oil 为溶剂， 反应 22.0h， 生成 1-溴-4-(环戊基磺酰基)苯
  参考文献：
  名称：

  Identification of biaryl sulfone derivatives as antagonists of the histamine H3 receptor: Discovery of (R)-1-(2-(4′-(3-methoxypropylsulfonyl)biphenyl-4-yl)ethyl)-2-methylpyrrolidine (APD916)

  摘要：

  The design of a new clinical candidate histamine-H-3 receptor antagonist for the potential treatment of excessive daytime sleepiness (EDS) is described. Phenethyl-R-2-methylpyrrolidine containing biphenylsulfonamide compounds were modified by replacement of the sulfonamide linkage with a sulfone. One compound from this series, 2j (APD916) increased wakefulness in rodents as measured by polysomnography with a duration of effect consistent with its pharmacokinetic properties. The identification of a suitable salt form of 2j allowed it to be selected for further development. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.11.075

文献信息

• 2-PYRIDONE COMPOUNDS
  申请人：KAWAGUCHI Takanori

  公开号：US20110237791A1

  公开（公告）日：2011-09-29

  A 2-pyridone compound represented by the formula [1]: wherein in the formula [1], the ring represented by A represents a benzene ring or a pyridine ring, X represents any of the structures represented by the formulas [3] shown below: V represents a single bond or a lower alkylene group, and W represents a single bond, an ether bond or a lower alkylene group (wherein the lower alkylene group may contain an ether bond)}, a tautomer or stereoisomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof is a compound that has an excellent GK activating effect and is useful as a pharmaceutical.

  化学式为[1]所代表的2-吡啶酮化合物： 其中在化学式[1]中， 由A代表苯环或吡啶环表示的环， X代表下面所示的化学式[3]所代表的任意结构： V代表单键或较低的烷基链，以及 W代表单键、醚键或较低的烷基链（其中较低的烷基链可能含有醚键）}， 该化合物的异构体或立体异构体，其药学上可接受的盐，或其溶剂化合物是一种具有出色的GK激活效果并且可用作药物的化合物。
• 11,21-bisphenyl-19-norpregnane derivatives
  申请人：Akzo Nobel N.V.

  公开号：US05620966A1

  公开（公告）日：1997-04-15

  The invention relates to a 11,21-bisphenyl-19-norpregnane derivative of formula I ##STR1## wherein R.sub.1 is selected from H, halogen, (1-6C)alkoxy, and NR.sub.5 R.sub.6, R.sub.5 and R.sub.6 being independently hydrogen or (1-6C)alkyl or R.sub.5 and R.sub.6 together are (3-6C)alkylene; R.sub.2 is hydrogen; or R.sub.1 and R.sub.2 together are a (1-3C)alkylenedioxy group, optionally substituted by one or more halogen atoms; R.sub.3 is methyl or ethyl; R.sub.4 is selected from C(O)-NR.sub.5 R.sub.6, SO.sub.n -(1-6C)alkyl optionally substituted by one or more halogen atoms, SO.sub.n -(3-6C)cycloalkyl, n being 1 or 2, SO.sub.2 -NR.sub.5 R.sub.6, 2-oxypyrrolidinyl, and NR.sub.5 R.sub.6 ; R.sub.7 is H or (1-6C)alkyl; R.sub.8 is H or carboxy-1-oxo(1-6C)alkyl; and X is selected from (H,OH), O, and NOH; 11 or a pharmaceutically acceptable salt thereof. The compounds of the invention have anti-glucocorticoid activity and can be used in treating or preventing glucocorticoid-dependent diseases.

  该发明涉及一种式I的11,21-双苯基-19-去甾烷衍生物##STR1##其中R.sub.1从H、卤素、(1-6C)烷氧基和NR.sub.5 R.sub.6中选择，R.sub.5和R.sub.6独立地为氢或(1-6C)烷基，或者R.sub.5和R.sub.6一起为(3-6C)烷基; R.sub.2为氢; 或者R.sub.1和R.sub.2一起为(1-3C)烷二氧基基团，可选地被一个或多个卤素原子取代; R.sub.3为甲基或乙基; R.sub.4从C(O)-NR.sub.5 R.sub.6、SO.sub.n -(1-6C)烷基（可选地被一个或多个卤素原子取代）、SO.sub.n -(3-6C)环烷基、n为1或2、SO.sub.2 -NR.sub.5 R.sub.6、2-氧基吡咯烷基和NR.sub.5 R.sub.6中选择; R.sub.7为H或(1-6C)烷基; R.sub.8为H或羧基-1-氧代(1-6C)烷基; X从(H,OH)、O和NOH中选择; 11或其药学上可接受的盐。该发明的化合物具有抗糖皮质激素活性，可用于治疗或预防糖皮质激素依赖性疾病。
• GLUCOKINASE ACTIVATORS
  申请人：Cheruvallath Zacharia

  公开号：US20070213349A1

  公开（公告）日：2007-09-13

  Compounds are provided for use with glucokinase that comprise the formula: wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.

  提供了用于与葡萄糖激酶一起使用的化合物，其化学式为：其中变量如本处所定义。还提供了包含这些化合物的药物组合物、工具包和制造品；用于制造这些化合物的方法和中间体；以及使用这些化合物的方法。
• [EN] PHENETANOLAMINE DERIVATIVES<br/>[FR] DERIVES DE PHENETANOLAMINE
  申请人：GLAXO GROUP LTD

  公开号：WO2005044787A1

  公开（公告）日：2005-05-19

  Compounds of formula (I) and salts, solvates, and physiologically functional derivatives thereof, useful for the prophylaxis or treatment of a clinical condition for which a selective β2-adrenoreceptor agonist is indicated, for example asthma or chronic obstructive pulmonary disease (COPD).

  化合物的化学式(I)及其盐、溶剂合物和生理功能衍生物，可用于预防或治疗需要选择性β2-肾上腺素受体激动剂的临床病症，例如哮喘或慢性阻塞性肺疾病（COPD）。
• Photocatalyzed site-selective C(sp3)-H sulfonylation of toluene derivatives and cycloalkanes with inorganic sulfinates
  作者：Shaonan Zhang、Shi Cao、Yu-Mei Lin、Liyuan Sha、Cheng Lu、Lei Gong

  DOI：10.1016/s1872-2067(21)63953-0

  日期：2022.3

  The development of practical methods for the direct and selective C(sp3)-H functionalization of hydrocarbons is an attractive topic in synthetic chemistry. Although the radical-mediated hydrogen atom transfer (HAT) process has shown considerable potential in such reactions, it still faces fundamental problems associated with reactivity and selectivity. Herein, we report a convenient and economic approach

  开发用于烃的直接和选择性C( sp 3 )-H 官能化的实用方法是合成化学中的一个有吸引力的课题。尽管自由基介导的氢原子转移 (HAT) 过程在此类反应中显示出相当大的潜力，但它仍然面临与反应性和选择性相关的基本问题。在此，我们报告了一种方便且经济的位点选择性 C( sp 3 ) -H 磺酰化方法光诱导的 HAT 催化。使用共轭多环醌作为直接 HAT 光催化剂，市售无机亚磺酸盐作为磺酰化源，三氟甲磺酸铜作为廉价氧化剂，多种甲苯衍生物和环烷烃在温和条件下转化为生物和合成有趣的砜产品。机理研究表明，反应顺序涉及直接 HAT 诱导的自由基形成和随后的铜介导的有机金属过程以形成 CS 键。这种方法提供了一个吸引人的机会，可以从丰富的碳氢化合物起始材料和廉价的试剂中提供高附加值的产品。